1. Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-γ after differentiation of glioblastoma by human natural killer cells
    Anna K. Kozlowska et al, 2016, Cancer Immunol Immunother CrossRef
  2. miR-340 inhibits glioblastoma cell proliferation by suppressing CDK6, cyclin-D1 and cyclin-D2
    Xuesong Li et al, 2015, Biochemical and Biophysical Research Communications CrossRef
  3. Identification of CD90 as a marker for lung cancer stem cells in A549 and H446 cell lines.
    Xiuping Yan et al, 2013, Oncol Rep CrossRef
  4. Enhancement of SOX-2 expression and ROS accumulation by culture of A172 glioblastoma cells under non-adherent culture conditions
    CHANG-NIM IM et al, 2015 CrossRef
  5. The Impact of Non-Lethal Single-Dose Radiation on Tumor Invasion and Cytoskeletal Properties
    Tim Hohmann et al, 2017, IJMS CrossRef
  6. Stress stimuli induce cancer-stemness gene expression via Sp1 activation leading to therapeutic resistance in glioblastoma
    Kwang-Yu Chang et al, 2017, Biochemical and Biophysical Research Communications CrossRef
  7. Establishment of a tumor sphere cell line from a metastatic brain neuroendocrine tumor
    Ryoichi Iwata et al, 2017, Med Mol Morphol CrossRef
  8. Comparison of Cellular Transforming Activity of OCT4, NANOG, and SOX2 in Immortalized Astrocytes
    Sunyoung Seo et al, 2017, DNA and Cell Biology CrossRef
  9. Cellular toxicity driven by high-dose vitamin C on normal and cancer stem cells.
    Tae-Jun Kim et al, 2018, Biochem Biophys Res Commun CrossRef
  10. Glioblastoma Cell Lines Display Different Sensitivities to Plasma-Activated Medium
    Hiromasa Tanaka et al, 2018, IEEE Trans. Radiat. Plasma Med. Sci. CrossRef
  11. Prodigiosin stimulates endoplasmic reticulum stress and induces autophagic cell death in glioblastoma cells
    Shu-Yu Cheng et al, 2018, Apoptosis CrossRef
  12. Carnosine selectively inhibits migration of IDH-wildtype glioblastoma cells in a co-culture model with fibroblasts
    Henry Oppermann et al, 2018, Cancer Cell Int CrossRef
  13. Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma Cells
    Maria Basile et al, 2018, Molecules CrossRef
  14. A New Patient-Derived Metastatic Glioblastoma Cell Line: Characterisation and Response to Sodium Selenite Anticancer Agent
    Sylvie Berthier et al, 2018, Cancers CrossRef
  15. Rapid Magnetic 3D Printing of Cellular Structures with MCF-7 Cell Inks
    S. Mishriki et al, 2019, Research CrossRef
  16. Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes
    Yang Xiao et al, 2019, Adv. Sci. CrossRef
  17. Targeting Glioma Stem Cells by Functional Inhibition of Dynamin 2: A Novel Treatment Strategy for Glioblastoma
    Rodney Luwor et al, 2019, Cancer Investigation CrossRef
  18. Differential propagation of stroma and cancer stem cells dictates tumorigenesis and multipotency
    J Behnan et al, 2017, Oncogene CrossRef
  19. Rapid Magnetic 3D Printing of Cellular Structures with MCF-7 Cell Inks
    S. Mishriki et al, 2019, Research CrossRef
  20. null
    Mia Dahl Sørensen et al, 2015 CrossRef
  21. The feasibility of using dielectrophoresis for isolation of glioblastoma subpopulations with increased stemness
    Nastaran Alinezhadbalalami et al, 2019, ELECTROPHORESIS CrossRef
  22. Circadian properties of cancer stem cells in glioma cell cultures and tumorspheres
    Vishal Premdev Sharma et al, 2014, Cancer Letters CrossRef
  23. Cells Isolated from Human Glioblastoma Multiforme Express Progesterone-Induced Blocking Factor (PIBF)
    Dobroslav Kyurkchiev et al, 2014, Cell Mol Neurobiol CrossRef
  24. Inhibitory Activities of Trichostatin A in U87 Glioblastoma Cells and Tumorsphere-Derived Cells
    Felipe de Almeida Sassi et al, 2014, J Mol Neurosci CrossRef
  25. Proteomic analysis underlines the usefulness of both primary adherent and stem-like cell lines for studying proteins involved in human glioblastoma
    Brigitte Collet et al, 2014, Journal of Proteomics CrossRef
  26. Isolation of cancer stem cells from three human glioblastoma cell lines: characterization of two selected clones.
    Fortunata Iacopino et al, 2014, PLoS ONE CrossRef
  27. The Cancer Stem Cell Hypothesis: A Guide to Potential Molecular Targets
    Alessandro Allegra et al, 2014, Cancer Investigation CrossRef
  28. MiR-21 up-regulation mediates glioblastoma cancer stem cells apoptosis and proliferation by targeting FASLG
    Chao Shang et al, 2015, Mol Biol Rep CrossRef
  29. Phenotypic Modulation and Neuroprotective Effects of Olfactory Ensheathing Cells: a Promising Tool for Cell Therapy
    Rosalia Pellitteri et al, 2016, Stem Cell Rev and Rep CrossRef
  30. Caffeine suppresses the progression of human glioblastoma via cathepsin B and MAPK signaling pathway
    Yu-Chen Cheng et al, 2016, The Journal of Nutritional Biochemistry CrossRef
  31. Suberoylanilide hydroxamic acid represses glioma stem-like cells
    Che-Chia Hsu et al, 2016, J Biomed Sci CrossRef
  32. null
    Begum Alural et al, 2017 CrossRef
  33. Dovitinib enhances temozolomide efficacy in glioblastoma cells
    Thatchawan Thanasupawat et al, 2017, Mol Oncol CrossRef
  34. Prolactin and its receptor as therapeutic targets in glioblastoma multiforme
    Antonela Sofía Asad et al, 2019, Sci Rep CrossRef
  35. NOS2 expression in glioma cell lines and glioma primary cell cultures: correlation with neurosphere generation and SOX-2 expression
    Paola Palumbo et al, 2017, Oncotarget CrossRef
  36. Mitochondrial DNA alterations may influence the cisplatin responsiveness of oral squamous cell carcinoma
    Amnani Aminuddin et al, 2020, Sci Rep CrossRef
  37. Patient-derived glioblastoma stem cells respond differentially to targeted therapies
    Pratik Kanabur et al, 2016, Oncotarget CrossRef
  38. A new tyrosine kinase inhibitor K905-0266 inhibits proliferation and sphere formation of glioblastoma cancer cells
    Senthilkumar Kalimuthu et al, 2020, Journal of Drug Targeting CrossRef
  39. Is There Such a Thing as a Genuine Cancer Stem Cell Marker? Perspectives from the Gut, the Brain and the Dental Pulp
    O. Crende et al, 2020, Biology CrossRef
  40. ADAMTS1 Supports Endothelial Plasticity of Glioblastoma Cells with Relevance for Glioma Progression
    Orlando Serrano-Garrido et al, 2020, Biomolecules CrossRef
  41. Evolution of Experimental Models in the Study of Glioblastoma: Toward Finding Efficient Treatments
    Ricardo Gómez-Oliva et al, 2021, Front. Oncol. CrossRef
  42. A cancer‐associated CDKN1B mutation induces p27 phosphorylation on a novel residue: a new mechanism for tumor suppressor loss‐of‐function
    Debora Bencivenga et al, 2021, Mol Oncol CrossRef
  43. Dissecting the mechanism of temozolomide resistance and its association with the regulatory roles of intracellular reactive oxygen species in glioblastoma
    Chia-Hung Chien et al, 2021, J Biomed Sci CrossRef
  44. Musashi-1 Regulates MIF1-Mediated M2 Macrophage Polarization in Promoting Glioblastoma Progression
    Yi-Ping Yang et al, 2021, Cancers CrossRef
  45. Exploiting the anticancer effects of a nitrogen bisphosphonate nanomedicine for glioblastoma multiforme
    Lynn N Jena et al, 2021, J Nanobiotechnol CrossRef
  46. On-chip perivascular niche supporting stemness of patient-derived glioma cells in a serum-free, flowable culture
    Magda Gerigk et al, 2021, Lab Chip CrossRef
  47. Androgen Receptor, Although Not a Specific Marker For, Is a Novel Target to Suppress Glioma Stem Cells as a Therapeutic Strategy for Glioblastoma
    Nan Zhao et al, 2021, Front. Oncol. CrossRef
  48. The Impact of Astrocytes and Endothelial Cells on Glioblastoma Stemness Marker Expression in Multicellular Spheroids
    Pinaki S. Nakod et al, 2021, Cel. Mol. Bioeng. CrossRef
  49. Glioblastoma Contains Topologically Distinct Proliferative and Metabolically Defined Subpopulations of Nestin- and Glut1-Expressing Cells
    Michael Prosniak et al, 2021 CrossRef
  50. Combinatorial Effect of Temozolomide and Naringenin in Human Glioblastoma Multiforme Cell Lines
    Megha Gautam et al, 2021, Nutrition and Cancer CrossRef
  51. Disrupting the CXCL12/CXCR4 axis disturbs the characteristics of glioblastoma stem-like cells of rat RG2 glioblastoma
    Chin-Cheng Lee et al, 2013, Cancer Cell Int CrossRef
  52. Evaluation of Comprehensive Gene Expression and NK Cell-Mediated Killing in Glioblastoma Cell Line-Derived Spheroids
    Takayuki Morimoto et al, 2021, Cancers CrossRef
  53. SOX transcription factors and glioma stem cells: Choosing between stemness and differentiation
    Milena Stevanovic et al, 2021, WJSC CrossRef
  54. Robust Quantification of Regional Patterns of Migration in Three-Dimensional Cell Culture Models
    Chun Kiet Vong et al, 2022, J. Med. Biol. Eng. CrossRef
  55. Ion Channel Drugs Suppress Cancer Phenotype in NG108-15 and U87 Cells: Toward Novel Electroceuticals for Glioblastoma
    Juanita Mathews et al, 2022, Cancers CrossRef
  56. A protocol to enrich in undifferentiated cells from neuroblastoma tumor tissue samples and cell lines
    Aida Amador-Álvarez et al, 2022, STAR Protocols CrossRef
  57. Evaluation of miRNA Expression in Glioblastoma Stem-Like Cells: A Comparison between Normoxia and Hypoxia Microenvironment
    Lucy Macharia et al, 2022, Onco CrossRef
  58. Glioblastoma, from disease understanding towards optimal cell-based in vitro models
    Chiara Boccellato et al, 2022, Cell Oncol. CrossRef
  59. The impact of temozolomide and lonafarnib on the stemness marker expression of glioblastoma cells in multicellular spheroids
    Pinaki S. Nakod et al, 2022, Biotechnology Progress CrossRef
  60. PLGA–Nano-Encapsulated Disulfiram Inhibits Hypoxia-Induced NF-κB, Cancer Stem Cells, and Targets Glioblastoma In Vitro and In Vivo
    Vinodh Kannappan et al, 2022 CrossRef
  61. Association of Glioma CD44 Expression with Glial Dynamics in the Tumour Microenvironment and Patient Prognosis
    Zhanxin Du et al, 2022, Computational and Structural Biotechnology Journal CrossRef
  62. The Barretos Cancer Hospital Animal Facility: Implementation and Results of a Dedicated Platform for Preclinical Oncology Models
    Silvia A. Teixeira et al, 2022, Veterinary Sciences CrossRef
  63. Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2
    Lanyang Xu et al, 2023, Phytomedicine CrossRef
  64. Effects of Dendrimer-microRNA Nanoformulations against Glioblastoma Stem Cells
    Nadezhda Knauer et al, 2023, Pharmaceutics CrossRef
  65. Methylcellulose/agarose hydrogel loaded with short electrospun PLLA/laminin fibers as an injectable scaffold for tissue engineering/3D cell culture model for tumour therapies
    Beata Niemczyk-Soczynska et al, 2023, RSC Adv. CrossRef
  66. Investigating Trans-differentiation of Glioblastoma Cells in an In Vitro 3D Model of the Perivascular Niche
    Rosalyn R. Hatlen et al, 2023, ACS Biomater. Sci. Eng. CrossRef
  67. Evaluating glioblastoma tumour sphere growth and migration in interaction with astrocytes using 3D collagen-hyaluronic acid hydrogels
    Yixiao Cui et al, 2023, J. Mater. Chem. B CrossRef
  68. Effect of microserum environment stimulation on extraction and biological function of colorectal cancer stem cells
    Feiqing Wang et al, 2023, Discov Onc CrossRef
  69. Endoplasmic reticulum regulation of glucose metabolism in glioma stem cells
    María Turos‑Cabal et al, 2023, Int J Oncol CrossRef
  70. An overview of glioblastoma multiforme in vitro experimental models
    Alessandra Maria Vitale et al, 2024, J Biol Res CrossRef
  71. Evaluation of the theranostic potential of [64Cu]CuCl2 in glioblastoma spheroids
    Catarina I. G. Pinto et al, 2024, EJNMMI Res CrossRef
  72. Hinokitiol Inhibits Breast Cancer Cells In Vitro Stemness-Progression and Self-Renewal with Apoptosis and Autophagy Modulation via the CD44/Nanog/SOX2/Oct4 Pathway
    Yi-Fen Chiang et al, 2024, IJMS CrossRef